China Pharma Holdings (CPHI) Q1 EPS Halves to 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $0.96 +12.94%
Financial Fact:
Net other income: -1.73M
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Net other income: -1.73M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q1 EPS of $0.06, versus $0.12 reported last year. Revenue for the quarter came in at $16.1 million, versus $18.1 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Jefferies names top MENA tech and telecom stocks amid fiscal shifts
- Sony credit outlook bumped to positive at Moody’s as A2 rating affirmed
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
